1[1]Albertsson M.Chemoradiotherapy of esophageal cancer [J].Acta Oncol,2002,41(2):118-123. 被引量：1
2[2]Geh JI. The use of chemoradiotherapy in oesophageal cancer [J]. Eur J Cancer, 2002,38(2):300-313. 被引量：1
3[3]Ajani JA, Ilson DH, Kelsen DP.The activity of paclitaxel in gastrointestinal tumors[J]. Semin Oncol.1995,22(5 Suppl 12):46-50. 被引量：1
4[4]Ajani JA, Baker J, Pisters PW, et al. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma [J]. Cancer, 2002,94(3):641-646. 被引量：1
5[5]Boku N, Ohtsu A, Shimada C, et al. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer [J]. J Clin Oncol, 1999,17(1):319-323. 被引量：1
6[6]Ajani JA,Baker J,Pisters PW,et al.Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma[J]. Oncology(Huntingt),2001,15(3 Suppl 5):52-54. 被引量：1
7[7]Coia LR, Minsky BD, Berkey BA, et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 patterns of care study [J]. J Clin Oncol, 2000,18(3):455-462. 被引量：1
8[8]Minsky BO, Berkey B, Kelsen DK, et al. Preliminary results of intergroup INT 0123 randomized trial of combined modality therapy (CMT) for esophageal cancer: standard vs high dose radiation therapy [J]. Proc Am Soc Clin Oncol, 2000,19:239a. 被引量：1
9[9]Al-Sarraf M,Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer. An intergroup study [J]. J Clin Oncol, 1997,15(2):866. 被引量：1
10[10]Wilson KS, Wilson AG, Dewar GJ. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998 [J]. Can J Gastroenterol, 2002,16(6):361-368. 被引量：1
